In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Antitope Ltd. Announces EpiScreen Agreement With GlaxoSmithKline plc.
Crucell Announces STAR® Technology Research License with Korean-based ISU ABXIS
Antitope Ltd Announces EpiScreen™ Collaboration With Centocor Inc
Fusion Antibodies announces antibody research agreement with Antitope
Antitope, Ltd., Announces Antibody Research Agreement With NKT Therapeutics, Inc.
ImmunoCellular Therapeutics signs with Antitope for Humanization of Antibody Product Candidates
Antitope Ltd and Vascular Pharmaceuticals Enter into a Antibody Research Agreement
MorphoSys announces extension of antibody collaboration with Bayer